• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Lupin Ltd.
    04 Jul 2025
    US FDA Observation
    2055.60
    0.44%
    Lupin launches nasal spray in US, part of 200-drug pipeline by FY30
    Business Standard
    The product, launched in the US market, is a generic version of Atrovent and part of Lupin's plan to scale complex generics revenue share to 62 per cent by FY30
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. has an average target of 2326.00 from 8 brokers.
    Lupin launches generic Ipratropium Bromide nasal spray in US market
    Business Line | 04 Jul 2025
    logo
    Aurobindo Pharma Ltd.
    04 Jul 2025
    1119.20
    -0.86%
    Buy Or Sell: Aurobindo Pharma, LIC Housing Finance On Ajit Mishra's Radar Check Target Price
    Buy Or Sell: Aurobindo Pharma, LIC Housing Finance On Ajit Mishra's Radar Check Target Price
    NDTV Profit
    The stock recommendations carry specific stop loss and target price.
    Copy LinkShare onShare on Share on Share on
    Promoters pledged 0.16% of shares in last quarter. Total pledge stands at 17.08% of promoter holdings
    logo
    Cipla Ltd.
    04 Jul 2025
    1575.80
    -0.15%
    Cipla faces revenue and margin pressure ahead of Revlimid patent expiry
    Cipla faces revenue and margin pressure ahead of Revlimid patent expiry
    Economic Times
    Cipla faces revenue and margin pressure due to the upcoming Revlimid patent expiry, leading to underperformance and analyst downgrades. Margin is expected to drop significantly in FY26 and FY27, with concerns about finding a suitable buyer after Torrent's acquisition of JB Chemicals. While Cipla is pursuing new respiratory and complex generic assets, analysts doubt these will fully offset Revlimid's decline.
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. is trading above all available SMAs
    logo
    Piramal Pharma Ltd.
    03 Jul 2025
    208.28
    2.43%
    Carlyle Group may sell 10% stake in Piramal Pharma via block deals: Report
    Business Standard
    Piramal Pharma sold 20 per cent of its stake to Carlyle Group in June 2020, in a deal worth 3,523 crore
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 257 to 247 in Jun 2025 qtr
    logo
    Sigachi Industries Ltd.
    03 Jul 2025
    44.20
    1.98%
    Sigachi Mishap: Expert panel begins investigation
    Business Line
    The blast occurredon June 30 morning when 143 workers were on duty in the plant of the drug-maker
    Copy LinkShare onShare on Share on Share on
    Sigachi Industries Ltd. average weekly volume is high.
    logo
    Alembic Pharmaceuticals Ltd.
    03 Jul 2025
    959.00
    0.17%
    Alembic Pharma Acquires Utility Therapeutics For $12 Million
    Alembic Pharma Acquires Utility Therapeutics For $12 Million
    NDTV Profit
    The acquisition is being done by Alembic Pharmaceuticals, Inc, the company's US subsidiary, Alembic said in a statement.
    Copy LinkShare onShare on Share on Share on
    Alembic Pharmaceuticals Ltd. is trading above its 200 day SMA of 949.1
    Alembic Pharmaceuticals up 2% as arm acquires Utility Therapeutics; details
    Business Standard | 03 Jul 2025 1 more
    Alembic acquires Utility Therapeutics for $12 mn
    Business Line | 03 Jul 2025
    logo
    Sigachi Industries Ltd.
    03 Jul 2025
    44.20
    1.98%
    T'gana plant explosion: Nine people missing, expert committee to visit site
    Business Standard
    As many as nine people are still missing in the explosion at the Sigachi Industries' pharma plant in Pashamylaram that claimed at least 38 lives and left 35 injured, and efforts are on to trace the missing people, Superintendent of Police (SP) of this district, Paritosh Pankaj, said on Thursday. Meanwhile, the expert committee appointed by the state government to ascertain the causes and establish the sequence of events that led to the explosion is expected to visit the site on Thursday. The panel should submit a detailed report with specific suggestions and recommendations, within a month, to the government. The committee will be headed by Dr B Venkateswar Rao, Emeritus Scientist, at CSIR-Indian Institute of Chemical Technology. A senior official of the district said some injured who are undergoing treatment in various hospitals are likely to be discharged today. "Death toll remains at 38. Nine people are missing. But maybe today or tomorrow, once we get the reports of bones and .
    Copy LinkShare onShare on Share on Share on
    Sigachi Industries Ltd. average weekly volume is high.
    logo
    Dr. Reddy's Laboratories Ltd.
    02 Jul 2025
    1321.70
    -0.08%
    Dr Reddy's expects US sales dip in FY26, aims for resilience via scale-up
    Business Standard
    With increased US competition from FY26, DRL plans portfolio shifts, inorganic growth, cost control and global expansion to manage profit and revenue impact
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
    Dr Reddy's preparing for challenges in the US Market in Q4
    Business Line | 02 Jul 2025
    logo
    Sigachi Industries Ltd.
    02 Jul 2025
    44.20
    1.98%
    40 staffers killed in blast at Telangana plant: Sigachi Industries
    Business Line
    Operations at the plant to remain suspended for approximately 90 days
    Copy LinkShare onShare on Share on Share on
    Sigachi Industries Ltd. average weekly volume is high.
    Telangana plant explosion: Sigachi used outdated machinery, says FIR
    Business Standard | 02 Jul 2025 6 more
    India factory fire death toll at 40, over 33 injured: Sigachi Industries
    Business Standard | 02 Jul 2025
    Sigachi Industries Shares Slump Nearly 11% Extending Decline To Third Day
    NDTV Profit | 02 Jul 2025
    Sigachi Industries Telangana Factory Blast: Plant Unit Has No NoC From Fire Department
    NDTV Profit | 02 Jul 2025
    Debris clearance almost over, Sigachi unit has no NoC from Fire Department
    Business Line | 02 Jul 2025
    How blast at Sigachi Industries' Hyd Plant leaves many unanswered questions?
    Business Line | 01 Jul 2025
    Govt, Sigachi to pay 1 cr compensation to blast victims: Telangana CM
    Business Standard | 01 Jul 2025
    logo
    AstraZeneca Pharma India Ltd.
    02 Jul 2025
    8934.50
    -1.54%
    AstraZeneca Pharma pops 4% on CDSCO nod to import Durvalumab solution
    Business Standard
    AstraZeneca Pharma shares rose after the company received regulatory approval to expand the use of its cancer drug Imfinzi (Durvalumab) in India.
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd. is trading above all available SMAs
    AstraZeneca considers moving its stock market listing to US: Report
    Business Standard | 01 Jul 2025
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Sampat Aluminium
    • Vms Tmt
    • JD Cables
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd